Joshua Meeks @JoshMeeks

Urologic Oncologist and Scientist at Northwestern University K-index:3.7 meekslab.org Chicago Joined July 2009

Tweets

2K
Followers

4K
Following

4K
Likes

14K

NM Urology @NM_Urology

a week ago

The @NorthwesternMed Urology Department is celebrating 125 years of excellence! As we celebrate this historic anniversary, watch as we honor pioneers in the field and reflect on just some of the achievements that exemplify our dedication to better urology. #NMBetter

1 9 37 2K 1

Download Video

Benjamin J. Davies MD @daviesbj

2 months ago

Priority review for TAR200 pretzel. A lot of uros are looking forward to giving this (as opposed to the other more hyped ones) jnj.com/media-center/p…

2 1 26 2K 0

Download Gif

Bladder Cancer Advocacy Network @BladderCancerUS

2 months ago

=> Please share! @PGrivasMDPhD @montypal @m_e_nielsen @SpiessPhilippe @FaltasLab @zklaassen_md @brian_rini @JoshMeeks @TiansterZhang @siadaneshmand @ERPlimackMD @shilpaonc @UroDocAsh @LauraBukavinaMD @sonpavde @urotoday @UrologyTimes

0 3 22 1K 0

Joshua Meeks @JoshMeeks

3 months ago

Deeply honored and truly grateful to @JedUro1 and @AndrewMcD_MD at @uabmedicine, @UABUrology, and @UABradonc for the incredible opportunity to serve as a special visiting professor in Birmingham discussing bladder preservation. Thank you for your generosity and hospitality!

1 9 77 3K 0

Download Image

Uromigos @Uromigos

3 months ago

@JoshMeeks provides an amazing overview of the significant data emerging in the BCG-unresponsive NMIBC space, focusing on the CIS cohorts. We also discuss the recent ODAC decision on UGN-102 for lower risk disease which was recently FDA approved. spotifycreators-web.app.link/e/szAiuFvyaUb

1 29 76 14K 32

Download Image

Benjamin Pradere @BenjaminPradere

3 months ago

Great pleasure during #AUA25 to discuss with @JoshMeeks and @UroDocAsh the futur of BCG naive field The tremendous @IBCG_BladderCA plenary session was fantastic, really enjoyed our debate leaded by @LAUrology_NL urotoday.com/video-lectures…

2 2 14 1K 1

UroToday.com @urotoday

3 months ago

Trials-in-Progress – Intravesical sacituzumab tirumotecan in participants with intermediate-risk #NMIBC: The phase 1/2 #TroFuse027 study. Presented by @JoshMeeks @NM_Urology. #ASCO25 written coverage by @RKSayyid @USC > bit.ly/4dMVaRk @ASCO

0 5 11 1K 2

Download Image

Toni Choueiri, MD @DrChoueiri

3 months ago

📢 #ASCO25 | NIAGARA ctDNA Analysis | MIBC pts on perioperative durvalumab: Baseline ctDNA+ in a subset linked to shorter EFS; early ctDNA clearance after D associated with improved DFS; persistent ctDNA post-surgery predicted relapse. Thomas Powles et al. Full abstract →…

1 20 49 3K 5

Download Image

Enrique Grande @drenriquegrande

3 months ago

#Niagara study at #ASCO25: Pre-surgery ctDNA is prognostic in perioperative MIBC. Being ctDNA– ≠ pCR, but if ctDNA+ → chances of pCR are close to zero. The real challenge: how should we define clinical CR to potentially avoid radical, mutilating surgery? Brilliant talk by…

0 10 23 1K 4

Download Image

Jussi Nikkola @JussiNikkola

3 months ago

NIAGARA ctDNA results presented at #ASCO25 🧬 ctDNA is prognostic ➡️ ctDNA negative patients have good DFS and ctDNA positive patient don’t do well Positive ctDNA pre-CX ➡️ negligible pCR ctDNA is making it’s way to clinical care 🩸🧬

0 7 12 1K 3

Download Image

GU Oncology Now @GUOncologyNow

3 months ago

👉 Dr. @tompowles1 shared the results of the phase 3 NIAGARA trial here at @ASCO. Read more about the study and its findings here: buff.ly/tJWHw65 #ASCO25

0 3 5 573 1

Tom Powles @tompowles1

3 months ago

1/2 ctDNA data for durvalumab+NAC in MIBC from NIAGARA #ASCO25. 57%,22%,9% of pts are ctDNA +ve at baseline/post NAC/post surgery. Poor outcomes for cDNA+ve occur at each time point (HR 0.4,0.3,0.1 respectively). Chemo cleared the ctDNA in most pts & was ⬆️13% with durvalumab

2 45 89 6K 35

Download Image

Joshua Meeks @JoshMeeks

4 months ago

One of my favorite things about spring is our annual visiting professor. Now named after Anthony J Schaeffer. This year we hosted James Eastham from @MSKCancerCenter. @NM_Urology.

1 6 67 3K 1

Download Image

LARVOL @Larvol

4 months ago

As May is Bladder Cancer Awareness Month, @Larvol CLIN highlights the top 10 trials from the @AmerUrological (AUA) 2025. Discover more: t.ly/efSba #LARVOL #AUA25 #BladderCancer #CancerResearch #Oncology #CancerData #ClinicalTrials #CancerCare #MIBC #NMIBC |…

1 18 37 16K 3

Download Image

BackTable Urology @_backtableUro

4 months ago

May is Bladder Cancer Awareness Month! 🧡 Throughout the month, we’ll be spotlighting recent episodes focused on this common but often overlooked disease. Stay tuned and help spread awareness! @BladderCancerUS @IBCG_BladderCA

0 4 12 1K 0

Joshua Meeks @JoshMeeks

4 months ago

The Future is BRIGHT! Excited for Leslie Ballas bladder preservation trial for responders after NAC. Love this trial, and aligns w much of what we do already. @SWOG @NRGonc @mouwlab

0 6 30 5K 5

Download Image

Joshua Meeks @JoshMeeks

4 months ago

Used @VanAllenLab recent AI review to prep for Vogelzang Symposium @SWOG @FaltasLab @Cancer_Cell

0 2 13 1K 0

Download Image

Northwestern Basic Sciences @NU_BSA

4 months ago

Please join us in congratulating Ali Shilatifard, PhD (@ShilatifardLab), the Robert Francis Furchgott Professor and chair of Biochemistry and Molecular Genetics, who has been elected to @theNASciences. Read the story: tinyurl.com/3kdn5f43